cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos]
RxNorm concept 1942745, branded drug component (sbdc).
- RxCUI
- 1942745
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942745 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
cytarabine liposome 100 MG / DAUNOrubicin liposomal 44 MG [Vyxeos]
Related concepts
- cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] (SBD, constitutes)
- Vyxeos (BN, has ingredient)
- cytarabine liposome 100 MG (SCDC, tradename of)
- daunorubicin liposomal 44 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1942745 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942745 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1942745. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.